Fascia Iliaca Versus Quadratus Lumborum Block for Pain Management in Total Hip Replacement.
1 other identifier
interventional
68
1 country
1
Brief Summary
Postoperative analgesia is essential for early ambulation of patients with hip arthroplasties as well as decreasing hospital stay time. Fascial plane blocks are emerging as a gold standard for postoperative analgesia instead of opioids and NSAIDs, with all there side effects. The investigators aim to compare postoperative pain levels and opioid analgesic needs of fascia iliaca block versus quadratus lumborum block in patients undergoing primary total hip arthroplasty under general anesthesia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 30, 2022
CompletedFirst Submitted
Initial submission to the registry
June 4, 2022
CompletedFirst Posted
Study publicly available on registry
August 17, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 3, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2022
CompletedJanuary 20, 2023
January 1, 2023
6 months
June 4, 2022
January 19, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Duration of postoperative analgesia
The investigators will measure the time to first analgesic request after giving the block
24 hours
Secondary Outcomes (2)
Total rescue analgesic requirements
24 hours
Functional recovery
72 hours
Study Arms (2)
Fascia iliaca block for postoperative pain management in hip arthroplasty
ACTIVE COMPARATORQuadratus lumborum block for postoperative pain management in hip arthroplasty
ACTIVE COMPARATORInterventions
Ultrasound guided fascia iliaca block done by palpation of anterior superior iliac spine to identify the inguinal crease, then place the ultrasound probe on it to identify the sartorius muscle. Sonographic anatomy will be identified, from superficial to deep, consisting of subcutaneous fat, the internal oblique muscle, the transverse abdominis muscle, the fascia iliaca covering the iliacus muscle and the iliacus muscle itself. The block needle will be advanced in out-of plane to puncture the fascia iliaca. With the needle tip just below the fascia iliaca, 2 ml of a local anesthetic will be injected to confirm the tip location. Once the proper position is confirmed, 40 ml of bupivacaine 0.25% will be injected superficial to the iliacus muscle and deep to the fascia iliaca.
The patients will receive anterior ultrasound guided quadratus lumborum block QLB in the lateral position. The transducer will be first placed in a parasagittal orientation 3-4 cm lateral to the midline and over the sacrum to identify the L5 transverse process. The probe will then rotated into a transverse orientation with slight medial and caudal angulation to obtain a transverse oblique view at L5 transverse process .The ultrasound probe will be tilted , so the lateral end of the probe will be more cranial than the medial side of the probe to avoid the acoustic shadow of the iliac crest. Identify the quadratus lumborum and psoas major and inject the local anesthetic above the QL
Eligibility Criteria
You may qualify if:
- All patients aging between 40-60 years ASA II, III with no known hypersensitivity for local anesthetics
You may not qualify if:
- Patient refusal
- Known allergy to local anesthetics
- Previous femoral artery surgery
- Local infection at the site of injection
- Those on anticoagulation therapy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ain Shams university hospitals
Cairo, 11566, Egypt
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
June 4, 2022
First Posted
August 17, 2022
Study Start
May 30, 2022
Primary Completion
December 3, 2022
Study Completion
December 30, 2022
Last Updated
January 20, 2023
Record last verified: 2023-01